Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOTUS trial of intradialytic parenteral nutrition in chronic hemodialysis
NL-OMON60539Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Intradialytic Parenteral Nutrition (Fresenius Kabi) in chronic kidney disease (CKD) (2 arms), sponsored by Erasmus MC. Primary endpoint: Difference in myofibrillar fractional synthetic rate. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Intradialytic Parenteral Nutrition (Fresenius Kabi)
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NL-OMON60539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60539.